Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 42Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Lung Neoplasms 19Congenital Abnormalities 17Kidney Neoplasms 16Rectal Neoplasms 15Lymphoma 15Head and Neck Neoplasms 15Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Melanoma 14Colonic Neoplasms 14Sarcoma 13Lymphoma, Follicular 11Carcinoma, Renal Cell 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Prostatic Neoplasms 9Leukemia, Myelomonocytic, Acute 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Central Nervous System Neoplasms 9Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Gliosarcoma 7Glioblastoma 7Esophageal Neoplasms 7

Interventions

pembrolizumab 161Carboplatin 145Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 38sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Gene Expression Profiling × Clear all
NCT00918892 2022-08-01

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Case Comprehensive Cancer Center

Completed
460 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡